Artificial intelligence in theranostics of gastric cancer, a review

10Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Gastric cancer (GC) is one of the commonest cancers with high morbidity and mortality in the world. How to realize precise diagnosis and therapy of GC owns great clinical requirement. In recent years, artificial intelligence (AI) has been actively explored to apply to early diagnosis and treatment and prognosis of gastric carcinoma. Herein, we review recent advance of AI in early screening, diagnosis, therapy and prognosis of stomach carcinoma. Especially AI combined with breath screening early GC system improved 97.4% of early GC diagnosis ratio, AI model on stomach cancer diagnosis system of saliva biomarkers obtained an overall accuracy of 97.18%, specificity of 97.44%, and sensitivity of 96.88%. We also discuss concept, issues, approaches and challenges of AI applied in stomach cancer. This review provides a comprehensive view and roadmap for readers working in this field, with the aim of pushing application of AI in theranostics of stomach cancer to increase the early discovery ratio and curative ratio of GC patients.

Cite

CITATION STYLE

APA

Zha, Y., Xue, C., Liu, Y., Ni, J., De La Fuente, J. M., & Cui, D. (2023, June 1). Artificial intelligence in theranostics of gastric cancer, a review. Medical Review. Walter de Gruyter GmbH. https://doi.org/10.1515/mr-2022-0042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free